COGT
Closed
Cogent Biosciences Inc
7.22
+0.04 (+0.56%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 7.18
Day's Range: 7.07 - 7.465
Send
sign up or login to leave a comment!
When Written:
10.79
Cogent Biosciences Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing precision therapies for patients with genetically defined diseases. The company's lead product candidate, CGT9486, is a selective tyrosine kinase inhibitor designed to target the genetic driver of fibrodysplasia ossificans progressiva (FOP), a rare and debilitating genetic disorder. Cogent Biosciences is also developing a pipeline of small molecule therapeutics for other genetically defined diseases, including cancer and autoimmune disorders. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








